NIFTY
569.40  5.32%
 11274.20
S&P BSE SENSEX
1921.15  5.32%
 38014.62
Dr. Lal Pathlabs Ltd.
NSE : LALPATHLAB BSE : 539524 ISIN code : INE600L01024
on 20-Sep-2019
NSE
70.4    5.65%
Rs. 1316.85
 
Days Low
Rs. 1245
Days High
Rs. 1333.95

Open Rs. 1275
 
52 week Low
Rs. 817
52 week High
Rs.1360
 
 
Bid :                 0.00 (0)
Offer :        0.00 (0)
BSE
Rs.1323.55
78.75    6.33%
on 20-Sep-2019
BSE
78.75    6.33%
Rs. 1323.55
 
Days Low
Rs. 1244.15
Days High
Rs. 1334.85

Open Rs. 1255.6
 
52 week Low
Rs. 813.45
52 week High
Rs.1360.05
 
 
Bid :                 0.00 (0)
Offer :        0.00 (0)
NSE
Rs.1316.85
70.4    5.65%
 
 
Last Price (Rs.)  1323.55 Value  15255390.00
Net Change (Rs.)  78.75 Best Buy  0.00
Volume  11691 Best Sell  0.00
Prev.Close (Rs.)  1244.80 Best Quantity  0
Open (Rs.)  1275.00 Sell Quantity  0
High (Rs.)  1333.95 52-Week High (Rs.)  1360.00
Low (Rs.)  1245.00 52-Week Low (Rs.)  817.00
Face Value (Rs.)  10 Market Cap.(Rs/ Mn)  110306.79
 
BSE
You need to upgrade your Flash Player
 
Financial (Rs .in Million)
Balance Sheet
Share Capital833.42 833.33 830.66 
Share Capital833.42 833.33 830.66 
Share Capital833.42 833.33 830.66 
Share Capital833.42 833.33 830.66 
Share Capital833.42 833.33 830.66 
Currents Investments1816.74 1438.51 1029.60 
More> 
 
Top 5 PeerCompanies * (Rs .in Million)
Company NameLTP* M.CapBVP/EDiv.Yield
Apollo Hospital Ent. 1468.70 204333 284.83 67.49 0.41
Fortis Healthcare 129.30 97616 116.68 79.31 0.00
Metropolis Health. 1246.20 62533 195.67 61.63 1.06
Aster DM Healthcare 121.60 61436 58.38 127.81 0.00
Narayana Hrudayalay 231.45 47299 58.04 94.44 0.00
 
Mutual Funds Holdings
 
Quarterly Result
(Rs .in millions)Jun 2019Mar 2019Dec 2018
Net Sales3245.002920.002828.00
Operating Profit1060.00771.00745.00
PBDT1023.00770.00743.00
Net Profit573.00460.00443.00
More> 
 
Company News
9/4/2019 12:00:00 AM
Dr Lal Pathlabs informs about schedule of analyst meet
8/14/2019 12:00:00 AM
Dr Lal Pathlabs zooms on reporting 19% rise in Q1 consolidated net pro...
8/13/2019 12:00:00 AM
Dr Lal Pathlabs reports 19% rise in Q1 consolidated net profit
More>
 
Ratios
   Earnings Per Share (Rs)23.45 
   Book NAV/Share(Rs)108.32 
   PAT Margin (%)16.78 
   Asset Turnover(x)1.21 
   PER(x)44.97 
   Yield(%)0.57 
   EV/Core EBITDA(x)25.24 
   M Cap / Sales7.54 
   Net Sales Growth(%)13.75 
   PAT Growth(%)16.15 
   Total Debt/Equity(x)0.00 
   Current Ratio(x)5.92 
   Quick Ratio(x)5.71 
   Total Debt/Mcap(x)0.00 
More>